The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia

Esatoğlu, SİNEM; Keskin, D; Eşkazan, AHMET; Elverdi, TUĞRUL; Salihoğlu, AYŞE; Ar, MUHLİS; Öngören, ŞENİZ; Başlar, Z; Aydin, Y; Uzun, H; Soysal, T

doi:10.3906/sag-2004-282

The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia

Esatoğlu S. N., Keskin D., Eşkazan A. E., Elverdi T., Salihoğlu A., Ar M. C., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.1, ss.348-354, 2021 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 51 Sayı: 1
Basım Tarihi: 2021
Doi Numarası: 10.3906/sag-2004-282
Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.348-354
Anahtar Kelimeler: Chronic lymphocytic leukemia, treatment, survival, prognosis, chemotherapy, SURVIVAL, BAFF
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background/aim: A proliferation-inducing ligand (APRIL) has been investigated as a prognostic marker in chronic lymphocytic leukemia (CLL) patients. However, there is no cut-off level for serum APRIL (sAPRIL) levels that predict time to treatment in CLL patients.